<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34534264</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Interactome screening of C9orf72 dipeptide repeats reveals VCP sequestration and functional impairment by polyGA.</ArticleTitle><Pagination><StartPage>684</StartPage><EndPage>699</EndPage><MedlinePgn>684-699</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awab300</ELocationID><Abstract><AbstractText>Repeat expansions in the C9orf72 gene are a common cause of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, two devastating neurodegenerative disorders. One of the proposed mechanisms of GGGGCC repeat expansion is their translation into non-canonical dipeptide repeats, which can then accumulate as aggregates and contribute to these pathologies. There are five different dipeptide repeat proteins (polyGA, polyGR, polyPR, polyPA and polyGP), some of which are known to be neurotoxic. In the present study, we used BioID2 proximity labelling to identify the interactomes of all five dipeptide repeat proteins consisting of 125 repeats each. We identified 113 interacting partners for polyGR, 90 for polyGA, 106 for polyPR, 25 for polyPA and 27 for polyGP. Gene Ontology enrichment analysis of the proteomic data revealed that these target interaction partners are involved in a variety of functions, including protein translation, signal transduction pathways, protein catabolic processes, amide metabolic processes and RNA-binding. Using autopsy brain tissue from patients with C9orf72 expansion complemented with cell culture analysis, we evaluated the interactions between polyGA and valosin containing protein (VCP). Functional analysis of this interaction revealed sequestration of VCP with polyGA aggregates, altering levels of soluble valosin-containing protein. VCP also functions in autophagy processes, and consistent with this, we observed altered autophagy in cells expressing polyGA. We also observed altered co-localization of polyGA aggregates and p62 in cells depleted of VCP. All together, these data suggest that sequestration of VCP with polyGA aggregates contributes to the loss of VCP function, and consequently to alterations in autophagy processes in C9orf72 expansion disorders.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bo&#x17e;i&#x10d;</LastName><ForeName>Janja</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motaln</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jane&#x17e;</LastName><ForeName>Anja Pucer</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marki&#x10d;</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripathi</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, RWTH Aachen University Medical School, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamoah</LastName><ForeName>Alfred</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, RWTH Aachen University Medical School, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronica</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, Department of (Neuro) Pathology, Amsterdam Neuroscience, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Youn-Bok</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 8AF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heilig</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>InViva Consulting Ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goswami</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, RWTH Aachen University Medical School, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogelj</LastName><ForeName>Boris</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3898-1943</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Jo&#x17e;ef Stefan Institute, Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute (BRIS), Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="C000614178">VCP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
          C9orf72
        </Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">VCP</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>17</Day><Hour>17</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34534264</ArticleId><ArticleId IdType="pmc">PMC9014755</ArticleId><ArticleId IdType="doi">10.1093/brain/awab300</ArticleId><ArticleId IdType="pii">6372042</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton AE, Majounie E, Waite A, et al. ; ITALSGEN Consortium . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A, Zalar M, &#x160;ket P, Plavec J, Rogelj B.. Anti-sense DNA d(GGCCCC)n expansions in C9ORF72 form i-motifs and protonated hairpins. Sci Rep. 2015;5:17944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4668579</ArticleId><ArticleId IdType="pubmed">26632347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Belzil VV, Zhang YJ, Petrucelli L.. Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol. 2014;127(3):359&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4002260</ArticleId><ArticleId IdType="pubmed">24394885</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;esnik AB, Darovic S, Mihevc SP, et al. . Nuclear RNA foci from C9ORF72 expansion mutation form paraspeckle-like bodies. J Cell Sci. 2019;132(5):jcs224303.</Citation><ArticleIdList><ArticleId IdType="pubmed">30745340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Ba&#xf1;ez-Coronel M, et al. . RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci USA. 2013;110(51):E4968&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, et al. . Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126(6):829&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Gr&#xe4;sser FA, et al. . Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126(6):881&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, Baskaran P, Gomez-Deza J, et al. . C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity. Hum Mol Genet. 2017;26(24):4765&#x2013;4777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886201</ArticleId><ArticleId IdType="pubmed">28973350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, et al. . Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345(6201):1139&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gr&#xf6;nke S, Niccoli T, et al. . C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345(6201):1192&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, et al. . Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84(6):1213&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens TG, Niccoli T, Wilson KM, et al. . C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019;137(3):487&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514073</ArticleId><ArticleId IdType="pubmed">30604225</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, et al. . GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525(7567):129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Grima JC, et al. . C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci. 2016;19(5):668&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Jansen-West K, Xu YF, et al. . Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 2014;128(4):505&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159567</ArticleId><ArticleId IdType="pubmed">25173361</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Gr&#xe4;sser FA, et al. . Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing [published correction appears in Acta Neuropathol. 2015 Oct;130(4):557-8]. Acta Neuropathol. 2015;130(4):537&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Motaln H, &#x10c;er&#x10d;ek U, Recek N, &#x10c;esnik Mozeti&#x10d; BA, Rogelj M.. B. Cold atmospheric plasma induces stress granule formation via an eIF2&#x3b1;-dependent pathway. Biomater Sci. 2020;7(19):5293&#x2013;5305.</Citation><ArticleIdList><ArticleId IdType="pubmed">32930691</ArticleId></ArticleIdList></Reference><Reference><Citation>Prpar Mihevc S, Baralle M, Buratti E, Rogelj B.. TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci Rep. 2016;6:33996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DI, Jensen SC, Noble KA, et al. . An improved smaller biotin ligase for BioID proximity labeling. Mol Biol Cell. 2016;27(8):1188&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4831873</ArticleId><ArticleId IdType="pubmed">26912792</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis S, Charles PD, He L, Mowlds P, Kessler BM, Fischer R.. Expanding proteome coverage with charge ordered parallel ion analysis (CHOPIN) combined with broad specificity proteolysis. J Proteome Res. 2017;16(3):1288&#x2013;1299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5363888</ArticleId><ArticleId IdType="pubmed">28164708</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister GC, Nusinow DP, Jedrychowski MP, et al. . MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal Chem. 2014;86(14):7150&#x2013;7158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215866</ArticleId><ArticleId IdType="pubmed">24927332</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizca&#xed;no JA, Csordas A, Del-Toro N, et al. . 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2016;44(22):11033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5159556</ArticleId><ArticleId IdType="pubmed">27683222</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xe4;ll L, Canterbury JD, Weston J, Noble WS, MacCoss MJ.. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods. 2007;4(11):923&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pubmed">17952086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. ; WFN Research Group on ALS/MND . A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Front Degener. 2015;16(5-6):291&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Goswami A, Jesse CM, Chandrasekar A, et al. . Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies. Neuropathol Appl Neurobiol. 2015;41(3):304&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">24957221</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A, Vollrath JT, Sechi A, et al. . The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. 2017;24(10):1655&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L, Drexler HCA, Wang J, et al. . FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138 (1):67&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamoah A, Tripathi P, Sechi A, et al. . Aggregates of RNA binding proteins and ER chaperones linked to exosomes in granulovacuolar degeneration of the Alzheimer&#x2019;s disease brain. J Alzheimer&#x2019;s Dis. 2020;75(1):139&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">32250292</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux KJ, Kim DI, Burke B, May DG.. BioID: A screen for protein-protein interactions. Curr Protoc Protein Sci. 2018;91(1):19.23.1&#x2013;19.23.15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028010</ArticleId><ArticleId IdType="pubmed">29516480</ArticleId></ArticleIdList></Reference><Reference><Citation>Callister JB, Ryan S, Sim J, Rollinson S, Pickering-Brown SM.. Modelling C9orf72 dipeptide repeat proteins of a physiologically relevant size. Hum Mol Genet. 2016;25(23):5069&#x2013;5082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886041</ArticleId><ArticleId IdType="pubmed">27798094</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R, Crippa V, Vezzoli G, et al. . The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperones. 2018;23(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, et al. . C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167(3):774&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz A, Marques JP, Oertig I, Maharjan N, Saxena S.. Emerging perspectives on dipeptide repeat proteins in C9ORF72 ALS/FTD. Front Cell Neurosci. 2021;18:637548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930069</ArticleId><ArticleId IdType="pubmed">33679328</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, et al. . Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92(2):383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP.. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci. 2017;13:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Guo L, Gonzales PK, et al. . Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science. 2019;363(6428):eaav2606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524780</ArticleId><ArticleId IdType="pubmed">30765536</ArticleId></ArticleIdList></Reference><Reference><Citation>White MR, Mitrea DM, Zhang P, et al. . C9orf72 Poly(PR) dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function. Mol Cell. 2019;74(4):713&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6525025</ArticleId><ArticleId IdType="pubmed">30981631</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Lempicki RA.. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Tan Q, et al. . DAVID bioinformatics resources: Expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(Web Server issue):W169&#x2013;W175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1933169</ArticleId><ArticleId IdType="pubmed">17576678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Hornburg D, Czuppa M, et al. . Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci Alliance. 2018;1(2):e201800070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Mori E, Kato M, et al. . Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell. 2016;167(3):789&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N. Autophagy: Process and function. Genes Dev. 2007;21(22):2861&#x2013;2873.</Citation><ArticleIdList><ArticleId IdType="pubmed">18006683</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Klionsky DJ.. New functions of a known autophagy regulator: VCP and autophagy initiation. Autophagy. 2021;17(5):1063&#x2013;1064. May</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143236</ArticleId><ArticleId IdType="pubmed">33784947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Wang R, Liu Y, Mei H, Liu X, Peng Z.. USP11 induce resistance to 5-fluorouracil in colorectal cancer through activating autophagy by stabilizing VCP. J Cancer. 2021;12(8):2317&#x2013;2325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974880</ArticleId><ArticleId IdType="pubmed">33758608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrobel L, Hill SM, Ashkenazi A, Rubinsztein DC.. VCP/p97 modulates PtdIns3P production and autophagy initiation. Autophagy. 2021;17(4):1052&#x2013;1053. Apr</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078685</ArticleId><ArticleId IdType="pubmed">33719912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengus C, Neutzner M, Bento ACPF, et al. . VCP/p97 cofactor UBXN1/SAKS1 regulates mitophagy by modulating MFN2 removal from mitochondria. Autophagy. Published online 9 May 2021. 10.1080/15548627.2021.1922982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1922982</ArticleId><ArticleId IdType="pmc">PMC8865314</ArticleId><ArticleId IdType="pubmed">33966597</ArticleId></ArticleIdList></Reference><Reference><Citation>Darwich NF, Phan JM, Kim B, et al. . Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science. 2020;370(6519):eaay8826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818661</ArticleId><ArticleId IdType="pubmed">33004675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein DC, Cuervo AM, Ravikumar B, et al. . In search of an &#x201c;autophagomometer&#x201d;. Autophagy. 2009;5(5):585&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">19411822</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M, Waguri S, Koike M, et al. . Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131(6):1149&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083104</ArticleId></ArticleIdList></Reference><Reference><Citation>Waguri S, Komatsu M.. Chapter 9 biochemical and morphological detection of inclusion bodies in autophagy-deficient mice. In: Klionsky DJ, ed. Autophagy in disease and clinical applications. Methods Enzymol. 2009;453:181&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">19216907</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdalla FC, Abeliovich H, et al. . Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3404883</ArticleId><ArticleId IdType="pubmed">22966490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju JS, Fuentealba RA, Miller SE, et al. . Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009;187(6):875&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bento AC, Bippes CC, Kohler C, Hemion C, Frank S, Neutzner A.. UBXD1 is a mitochondrial recruitment factor for p97/VCP and promotes mitophagy. Sci Rep. 2018;8(1):12415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6098094</ArticleId><ArticleId IdType="pubmed">30120381</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, Becker L, Garrett L, et al. . Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss. Acta Neuropathol. 2017;134(2):241&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5508040</ArticleId><ArticleId IdType="pubmed">28409281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, et al. . The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339(6125):1335&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, et al. . Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135(3):459&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>May S, Hornburg D, Schludi MH, et al. . C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 2014;128(4):485&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159571</ArticleId><ArticleId IdType="pubmed">25120191</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Flores BN, Krans A, et al. . The carboxyl termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS/FTD. Acta Neuropathol Commun. 2020;4:122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7401224</ArticleId><ArticleId IdType="pubmed">32753055</ArticleId></ArticleIdList></Reference><Reference><Citation>McEachin ZT, Gendron TF, Raj N, et al. . Chimeric peptide species contribute to divergent dipeptide repeat pathology in c9ALS/FTD and SCA36. Neuron. 2020;107(2):292&#x2013;305.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138626</ArticleId><ArticleId IdType="pubmed">32375063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, et al. . Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77(4):639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F, Schueder F, Tiwary S, et al. . The nucleolus functions as a phase-separated protein quality control compartment. Science. 2019;365(6451):342&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">31296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Baborie A, Griffiths TD, Jaros E, et al. . Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathol Appl Neurobiol. 2015;41(5):601&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4934135</ArticleId><ArticleId IdType="pubmed">25185840</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Yoon SJ, Gardner RC, et al. . Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain. 2016;139(Pt 12):3202&#x2013;3216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5790143</ArticleId><ArticleId IdType="pubmed">27797809</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Lehmer C, Mart&#xed;nez-S&#xe1;nchez A, et al. . In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell. 2018;172(4):696&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6035389</ArticleId><ArticleId IdType="pubmed">29398115</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Gr&#xe4;sser FA, et al. . Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 2015;130(6):845&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">26374446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E, et al. . Dipeptide repeat protein pathology in C9ORF72 mutation cases: Clinico-pathological correlations. Acta Neuropathol. 2013;126(6):859&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Hosokawa M, et al. . C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43. Hum Mol Genet. 2018;27(15):2658&#x2013;2670.</Citation><ArticleIdList><ArticleId IdType="pubmed">29750243</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Pfister V, Gaucherot A, et al. . Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39(4):e100574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Blythe EE, Gates SN, Deshaies RJ, Martin A.. Multisystem proteinopathy mutations in VCP/p97 increase NPLOC4&#xb7;UFD1L binding and substrate processing. Structure. 2019;27(12):1820&#x2013;1829.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6929323</ArticleId><ArticleId IdType="pubmed">31623962</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan M, Zheng Q, Yu Y, et al. . Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative. Nat Commun. 2021;12(1):121&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785736</ArticleId><ArticleId IdType="pubmed">33402676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukkavalli S, Klicksten JA, Oritz B, Juo P, Raman M.. The p97&#x2013;UBXN1 complex regulates aggresome formation. J Cell Sci. 2021;134 (7):jcs254201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077447</ArticleId><ArticleId IdType="pubmed">33712450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganji R, Mukkavalli S, Somanji F, Raman M.. The VCP-UBXN1 complex mediates triage of ubiquitylated cytosolic proteins bound to the BAG6 complex. Mol Cell Biol. 2018;38(13):e00154&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6002697</ArticleId><ArticleId IdType="pubmed">29685906</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H, Weihl CC.. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127(18):3877&#x2013;3883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4163641</ArticleId><ArticleId IdType="pubmed">25146396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H, Shoji K, Kiyokawa K, Negishi L, Tomari Y.. VCP machinery mediates autophagic degradation of empty argonaute. Cell Rep. 2019;28(5):1144&#x2013;1153.</Citation><ArticleIdList><ArticleId IdType="pubmed">31365860</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos C, Kirchner P, Bug M, et al. . VCP/p97 cooperates with YOD 1, UBXD 1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J. 2017;36(2):135&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5242375</ArticleId><ArticleId IdType="pubmed">27753622</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>